Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > EDNRB


Brief Information

Name:Endothelin receptor type B
Target Synonym:Hirschsprung Disease 2,Endothelin receptor non-selective type,ET-B,Endothelin receptor type B,EDNRB,ET-BR,ETRB,Endothelin Receptor Subtype B1,ABCDS,HSCR2,ETB1,ETBR,WS4A,HSCR,ETB,Receptor, Endothelin B
Number of Launched Drugs:5
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
Cat. No. Species Product Description Structure Purity Feature
EDB-HF2G4 Human Fluorescent Human EDNRB Full Length Protein (VLP)
EDB-H52P7 Human Human EDNRB Full Length Protein (VLP)
ACRO Quality

Part of Bioactivity data


Immobilized Human EDNRB Full Length Protein-VLP (Cat. No. EDB-H52P7) at 5 μg/mL (100 μL/well) can bind Anti-EDNRB Antibody, Human IgG1 with a linear range of 0.1-2 ng/mL (QC tested).


Immobilized Fluorescent Human EDNRB Full Length Protein (VLP) (Cat. No. EDB-HF2G4) at 2 μg/mL (100 μL/well) can bind Anti-EDNRB Antibody, Human IgG1 with a linear range of 0.001-0.003 μg/mL (QC tested).

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Sovateltide IRL-1620; PMZ-1620; SPI-1620 Approved University Of Illinois At Chicago Tyvalzi India Stroke Pharmazz Inc 2023-05-31 Brain Ischemia; Biliary Tract Neoplasms; Carcinoma; Spinal Cord Injuries; Asphyxia Neonatorum; Brain Diseases; Stroke; Hypoxia-Ischemia, Brain; Dementia; Alzheimer Disease; Cerebral Infarction; Carcinoma, Non-Small-Cell Lung Details
Macitentan/Tadalafil Approved Actelion Pharmaceuticals Ltd OPSYNVI United States Pulmonary Arterial Hypertension Actelion Pharmaceuticals Us Inc 2024-03-22 Pulmonary Arterial Hypertension Details
Bosentan Hydrate ACT-050088; HGP-1206; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039 Approved F. Hoffmann-La Roche Ltd Stayveer, 全可利, Tracleer United States Pulmonary Arterial Hypertension Actelion Pharmaceuticals Ltd 2001-11-20 Pulmonary Fibrosis; Heart Defects, Congenital; Diabetes Mellitus; Anemia, Sickle Cell; Persistent Fetal Circulation Syndrome; Ulcer; Sleep Apnea Syndromes; Glaucoma; Pulmonary Arterial Hypertension; Hypertension; Hepatopulmonary Syndrome; Hypertension, Pulmonary; Lung Diseases, Interstitial; Sarcoidosis; Liver Cirrhosis; Chronic thromboembolic pulmonary hypertension; Fibrosis; Scleroderma, Systemic; Idiopathic Pulmonary Fibrosis; Diabetes Mellitus, Type 2; Heart Septal Defects, Atrial Details
Macitentan ACT-064992; Actelion-1; JNJ-67896062 Approved Actelion Pharmaceuticals Ltd Zependo, Opsumit, 傲朴舒 United States Pulmonary Arterial Hypertension Actelion Pharmaceuticals Us Inc 2013-10-18 Hypertension, Pulmonary; Pulmonary Embolism; Heart Failure; Idiopathic Pulmonary Fibrosis; Scleroderma, Systemic; Chronic thromboembolic pulmonary hypertension; Glioblastoma; Lung Diseases, Interstitial; Thromboembolism; Pulmonary Arterial Hypertension; Eisenmenger Complex; Ulcer; Anemia, Sickle Cell; Chronic Disease; Heart Defects, Congenital Details
Aprocitentan ACT-132577; AC-080; JNJ-2820 Approved Idorsia Pharmaceuticals Ltd, Actelion Pharmaceuticals Ltd TRYVIO United States Hypertension Idorsia Pharmaceuticals Ltd 2024-03-19 Hypertension; Hepatic Insufficiency; Essential Hypertension; Renal Insufficiency, Chronic Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
VRP-1620 VRP-1620 Phase 3 Clinical University Of Illinois Breast Neoplasms Details
ENB-003 ENB-003 Phase 2 Clinical Enb Therapeutics Inc Ovarian Neoplasms; Solid tumours; Neoplasms; Pancreatic Neoplasms; Melanoma Details
BQ-788 BQ-788 Phase 1 Clinical Merck Serono Hypertension; Cardiovascular Diseases; Melanoma Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message